Slide 1©2004 Millennium Pharmaceuticals, Inc. © 2004 Millennium Pharmaceuticals Inc. Opportunities and Challenges in Utilizing Biomarkers for Drug Development Mark Chang,…

1.Group Difference MethodsBy Rama Krishna Kompella2. The basic ANCOVA situation• Three variables: 1 Categorical (IV), 1 Continuous (IV) which isa covariate, 1 Continuous…

Slide 1Understanding and Addressing Provider Contribution to Disparities Michelle van Ryn, Ph.D., M.P.H. Director, Colorectal Cancer Quality Enhancement Research Initiative,…

Slide 1 Propensity Score Matching Lava Timsina Kristina Rabarison CPH 786-001 Doctoral Seminar Fall 2012 Slide 2 Introduction Program evaluation Counterfactual outcome –…

Slide 1 MRD in myeloma UKMF Spring Day Assessment of disease response, CR and beyond. Roger Owen St James’s Institute of Oncology Leeds, UK Slide 2 Myeloma trials: the…

Slide 1 EXPERIMENTAL DESIGN Random assignment Who gets assigned to what? How does it work What are limits to its efficacy? Slide 2 RANDOM ASSIGNMENT Equal probability of…

Slide 1 Paths to precision medicine: Subgroup Identification in Clinical Trials Xin Huang, Yan Sun, V. Devanarayan Exploratory Statistics AbbVie Inc. April. 15, 2015 Slide…

Racial disparities in pain: A social-cognitive perspective Diana Burgess, PhD Core Investigator Center for Chronic Disease Outcomes Research (CCDOR) Assistant Professor University…